Achondroplasia

G Baujat, L Legeai-Mallet, G Finidori… - Best Practice & …, 2008 - Elsevier
Achondroplasia (MIM 100800) is the most common non-lethal skeletal dysplasia. Its
incidence is between one in 10 000 and one in 30 000. The phenotype is characterized by …

[PDF][PDF] Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia

F Lorget, N Kaci, J Peng, C Benoist-Lasselin… - The American Journal of …, 2012 - cell.com
Achondroplasia (ACH), the most common form of dwarfism, is an inherited autosomal-
dominant chondrodysplasia caused by a gain-of-function mutation in fibroblast-growth-factor …

Tyrosine kinase inhibitor NVP-BGJ398 functionally improves FGFR3-related dwarfism in mouse model

D Komla-Ebri, E Dambroise, I Kramer… - The Journal of …, 2016 - Am Soc Clin Investig
Achondroplasia (ACH) is the most frequent form of dwarfism and is caused by gain-of-
function mutations in the fibroblast growth factor receptor 3–encoding (FGFR3-encoding) …

Polymerase ε1 mutation in a human syndrome with facial dysmorphism, immunodeficiency, livedo, and short stature (“FILS syndrome”)

J Pachlopnik Schmid, R Lemoine, N Nehme… - Journal of Experimental …, 2012 - rupress.org
DNA polymerase ε (Polε) is a large, four-subunit polymerase that is conserved throughout
the eukaryotes. Its primary function is to synthesize DNA at the leading strand during …

Constitutively-active FGFR3 disrupts primary cilium length and IFT20 trafficking in various chondrocyte models of achondroplasia

L Martin, N Kaci, V Estibals, N Goudin… - Human molecular …, 2018 - academic.oup.com
Fibroblast growth factor receptor 3 (FGFR3) gain-of-function mutations cause dwarfisms,
including achondroplasia (ACH) and thanatophoric dysplasia (TD). The constitutive …

A novel tyrosine kinase inhibitor restores chondrocyte differentiation and promotes bone growth in a gain-of-function Fgfr3 mouse model

A Jonquoy, E Mugniery… - Human molecular …, 2012 - academic.oup.com
Activating germline fibroblast growth factor receptor 3 (FGFR3) mutations cause
achondroplasia (ACH), the most common form of human dwarfism and a spectrum of …

Advances in research on and diagnosis and treatment of achondroplasia in China

Y Wang, Z Liu, Z Liu, H Zhao, X Zhou… - Intractable & rare …, 2013 - jstage.jst.go.jp
Achondroplasia is a rare autosomal dominant genetic disease. Research on achondroplasia
in China, however, has received little emphasis. Around 80-90% of cases of neonatal …

New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profiling

L Schibler, L Gibbs, C Benoist-Lasselin, C Decraene… - PloS one, 2009 - journals.plos.org
Endochondral ossification is the process by which the appendicular skeleton, facial bones,
vertebrae and medial clavicles are formed and relies on the tight control of chondrocyte …

Caracterización, purificación y evaluación de la bioactividad de fitoquímicos obtenidos de fuentes naturales

ML Cádiz Gurrea - 2018 - digibug.ugr.es
La presente Tesis Doctoral recoge herramientas de análisis, purificación y evaluación de la
bioactividad de los compuestos fenólicos presentes en distintas especies vegetales, así …

Recent patents on Achondroplasia: latest research development

B Colligris, F Huete… - Recent Patents on …, 2013 - ingentaconnect.com
Achondroplasia (ACH) is the most common pathology of the group of disorders called
chondrodysplasias. It is resulting from a mutation in the Fibroblast Growth Factor Receptor …